CJ Fichtenbaum et al. Abacavir is associated with elevated risk for cardiovascular events in the REPRIEVE trial. International AIDS Conference. Friday, July 26, 2024
Abacavir linked to increased cardiovascular risk in HIV patients, study finds
- Post author:
- Post published:July 23, 2024
- Post category:uncategorized